Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178711-14-000038
Filing Date
2014-08-06
Accepted
2014-08-06 16:12:15
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q q22014form10q.htm 10-Q 706024
2 EXHIBIT exh101tspt5thamendmt.htm EX-10.1 18949
3 EXHIBIT exh311063014.htm EX-31.1 8977
4 EXHIBIT exh312063014.htm EX-31.2 8852
5 EXHIBIT exh321063014.htm EX-32.1 8504
  Complete submission text file 0001178711-14-000038.txt   4062426

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tspt-20140630.xml EX-101.INS 635287
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tspt-20140630.xsd EX-101.SCH 26731
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tspt-20140630_cal.xml EX-101.CAL 36664
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tspt-20140630_def.xml EX-101.DEF 85352
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tspt-20140630_lab.xml EX-101.LAB 313693
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tspt-20140630_pre.xml EX-101.PRE 166508
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 141020096
SIC: 2834 Pharmaceutical Preparations